BR100 Increased By (1.32%)
BR30 Increased By (1.33%)
KSE100 Increased By (1.37%)
KSE30 Increased By (1.47%)
AGHA 7.87 Increased By ▲ 0.12 (1.55%)
BECO 5.21 Increased By ▲ 0.02 (0.39%)
BML 59.45 Increased By ▲ 0.79 (1.35%)
BOP 34.37 Increased By ▲ 0.68 (2.02%)
CNERGY 10.92 Increased By ▲ 0.31 (2.92%)
CSIL 5.31 Increased By ▲ 0.01 (0.19%)
FCCL 54.34 Increased By ▲ 0.60 (1.12%)
FFL 16.83 Increased By ▲ 0.37 (2.25%)
FNEL 1.21 Decreased By ▼ -0.01 (-0.82%)
KEL 7.43 Increased By ▲ 0.15 (2.06%)
KOSM 5.72 Increased By ▲ 0.08 (1.42%)
LOTCHEM 30.02 Increased By ▲ 0.37 (1.25%)
MLCF 97.45 Increased By ▲ 1.09 (1.13%)
NBP 205.70 Increased By ▲ 2.17 (1.07%)
NCPL 58.11 Increased By ▲ 1.26 (2.22%)
NPL 69.42 Increased By ▲ 2.11 (3.13%)
OGDC 321.25 Increased By ▲ 3.03 (0.95%)
PACE 10.76 Increased By ▲ 0.13 (1.22%)
PAEL 42.54 Increased By ▲ 0.77 (1.84%)
PIBTL 17.16 Increased By ▲ 0.35 (2.08%)
PPL 223.78 Increased By ▲ 3.61 (1.64%)
PRL 52.84 Increased By ▲ 3.79 (7.73%)
PTC 71.10 Increased By ▲ 1.09 (1.56%)
SSGC 29.65 Increased By ▲ 0.51 (1.75%)
TBL 9.78 Increased By ▲ 0.01 (0.1%)
TELE 8.96 Increased By ▲ 0.14 (1.59%)
TPL 17.40 Increased By ▲ 0.23 (1.34%)
TPLP 12.86 Increased By ▲ 0.35 (2.8%)
TREET 22.90 Increased By ▲ 0.31 (1.37%)
TRG 60.60 Increased By ▲ 0.38 (0.63%)
World

Sweden to resume AstraZeneca jabs for over 65s

  • The vaccine is of great use for the elderly, among whom many fall seriously ill each day.
  • "At the same time, we haven't seen these rare and serious side effects among our elderly. That is the background to why we are lifting the suspension for people older than 65."
Published Updated

STOCKHOLM: Sweden will resume use of AstraZeneca's COVID-19 vaccine for people aged 65 and older, the health agency said on Thursday, but keep the pause in place for younger Swedes as it continues to investigate a potential link between the shots and rare cases of blood clots.

"The vaccine is of great use for the elderly, among whom many fall seriously ill each day," Director General Johan Carlson said in a statement on the agency's new guidelines to the regional authorities administering the vaccinations in Sweden.

"At the same time, we haven't seen these rare and serious side effects among our elderly. That is the background to why we are lifting the suspension for people older than 65."

Most countries which temporarily suspended the vaccine have now resumed administering shots following recommendations from the European Union's drug watchdog and the World Health Organization (WHO).

Both the European Medicines Agency (EMA) and the WHO said last week that the benefits of AstraZeneca's vaccine outweighed the risks.

Reuters

Comments

Comments are closed for this article.